Concentrics Research

Indianapolis, United States Founded: 1999 • Age: 27 yrs Acquired By Bindley Capital Partners
Late-stage (Phase II-IV trials) CRO

About Concentrics Research

Concentrics Research is a Healthcare company based in Indianapolis (United States) founded in 1999, and was acquired by Bindley Capital Partners in December 2002. Late-stage (Phase II-IV trials) CRO. The company has 47 employees. Concentrics Research offers products and services including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Late Stage. Its legal entity is CONCENTRICS RESEARCH, LLC. Its competitors include United BioSource Corporation, Launch Therapeutics and Nexus Biosciences; 1 of its 3 listed competitors has raised funding.

Company details

Concentrics Research is a CRO with capabilities to conduct Rx-to-OTC Switch and Late-Stage (Phase II-IV) for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. The companys CRO service portfolio includes Protocol development, Project Management, Site Management, Investigator Meeting Planning and Conduct, Start-upKick-off Meetings, Clinical Monitoring, Data Collection (various EDC methods as well as paper), Data Management, Statistical analysis and Medical Writing. They offer their clinical development services for drugs, medical devices and dietary supplements. Concentrics Research has 3 major divisions - CRO, Site Management Organization (Concentrics Center for Research), and Concentrics Strategy Center (Initiates and Facilitates study conduct). The research site has capabilities to conduct Qualitative pre-testing for Rx-to-OTC Switch studies, Clinical research studies and Specialized custom marketing research.

Key Metrics

Products & Services of Concentrics Research

Concentrics Research offers a comprehensive portfolio of products and services, including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.

Rx-to-OTC Switch
Switch Services

Service for transitioning prescription drugs to over-the-counter status.

Clinical Research
Research Services

Late-stage trials for drugs and devices in healthcare.

Healthcare Market Research
Market Analysis

Regulated research for healthcare marketing strategies.

Investors in Concentrics Research

Concentrics Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bindley Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Bindley Capital Partners is engaged in private investment management.
bindley.comIndianapolis, United States
Premium access

Investor details for Concentrics Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Concentrics Research

8 people are tracked at Concentrics Research (3 in leadership, 5 in team); the tracked headcount is 47.

NameRoleGroup
Julie Aker
President & Chief Executive OfficerLeadership
Sara Travis (Stuteville)
Vice President, OperationsLeadership
Melissa Beck
Director Project OperationsLeadership
Jamie Sanders
Associate Project ManagerTeam
Caroline Clark
Project ManagerTeam
Kimberly Neidigh
Clinical Research AssociateTeam
Nina Garrett
Clinical Operations Project Manager, IITeam
Kate Martin
Clinical Research Associate On Assignment With ExecupharmTeam
Premium access

Complete people profiles for Concentrics Research

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Concentrics Research

2 dated milestones of Concentrics Research across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Concentrics Research is founded.
  2. Exit Acquired by Bindley Capital Partners.

Competitors of Concentrics Research

Concentrics Research has 3 listed competitors in our database, 1 of them funded. They include United BioSource Corporation, Launch Therapeutics and Nexus Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ubc.com2003Blue Bell, United States$278M
Pharmaceutical support services
launchtx.com2022Boston, United States
Late-stage clinical development services are provided for biopharma companies.
nexusbiosciences.com2012Carlsbad, United States
CRO specializing in late stage, observational and post-approval studies
Premium access

Detailed competitors of Concentrics Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Concentrics Research

The website of Concentrics Research (concentricsresearch.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 302.9% vs previous month

Similar websites

Websites whose visitors overlap most with Concentrics Research. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
qualmedicaresearch.com
qualmedicaresearch.com
100%
–
indianaclinicalresearch.com
indianaclinicalresearch.com
99%
–
nccindiana.com
nccindiana.com
94%
#2,780,993–
urologyin.com
87%
14.6K#1,272,061View details
indianactsi.org
82%
16.1K#1,710,309View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Concentrics Research

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Concentrics Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Concentrics Research

Premium access

Complete news archive for Concentrics Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Concentrics Research

Concentrics Research was founded in 1999.

Concentrics Research is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.

Concentrics Research has 47 employees.

Concentrics Research is a CRO with capabilities to conduct Rx-to-OTC Switch and Late-Stage (Phase II-IV) for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. The companys CRO service portfolio includes Protocol development, Project Management, Site Management, Investigator Meeting Planning and Conduct, Start-upKick-off Meetings, Clinical Monitoring, Data Collection (various EDC methods as well as paper), Data Management, Statistical analysis and Medical Writing. They offer their clinical development services for drugs, medical devices and dietary supplements. Concentrics Research has 3 major divisions - CRO, Site Management Organization (Concentrics Center for Research), and Concentrics Strategy Center (Initiates and Facilitates study conduct). The research site has capabilities to conduct Qualitative pre-testing for Rx-to-OTC Switch studies, Clinical research studies and Specialized custom marketing research.

Concentrics Research's top competitors include United BioSource Corporation, Nexus Biosciences and Launch Therapeutics.

Concentrics Research offers Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.

Concentrics Research has 1 investor. Key investors include Bindley Capital Partners.

Concentrics Research operates through Concentrics Research, Llc.

Yes. Concentrics Research was acquired by Bindley Capital Partners in December 2002.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available